Pharma Pulse 10/11/24: Critical Conversations Between Supply Chain Teams, Mental Health May Play a Role in Vitiligo Treatment Efficacy & more

LogiPharma USA 2024: Critical Conversations Between Supply Chain Teams During API Sourcing

Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses critical conversations that supply chain teams and partners must partake in during API sourcing at LogiPharma USA 2024.

Mental Health May Play a Role in Vitiligo Treatment Efficacy, Study Shows

Mental health and vitiligo treattment outcomes may be associated because of a brain-skin axis, a pathway that links emotional stress to skin conditions.

Nobel Prize in Chemistry Awarded to Trio Who Cracked the Code of Proteins

Google DeepMind’s John Jumper and Demis Hassabis share honor with David Baker for transforming ability to understand human biology.

New Study: Patients Unlikely to See Out-Of-Pocket Drug Savings from the Inflation Reduction Act

New research contradicts promises of savings at the pharmacy counter for Medicare beneficiaries from the Inflation Reduction Act’s (IRA) drug pricing provisions. In fact, the study suggests some patients may pay more. In a research brief commissioned by We Work For Health with analysis performed by the IQVIA Institute for Human Data Science, researchers estimated what patients will actually pay for the 10 Part D medicines chosen by the Centers for Medicare and Medicaid Services for government price controls. The IQVIA Institute calculated how changes in Medicare coverage and other factors will impact patient out-of-pocket costs. The study reveals how unintended consequences of the law could lead to negative impacts for seniors, including increased costs and coverage barriers for certain medications.

Petauri on LinkedIn

High payer rejection rates faced by new drugs in the US market are a major challenge for biopharma companies. According to recent data reported by Pharmaceutical Executive, 69% are rejected within the first year of launch. To address this issue, it's essential to re-evaluate your payer launch strategies. Partnering with experts in this field can ensure that you are implementing best-in-class launch strategies that can improve patient access and maximize the commercial potential of your products. Read the full article here: https://lnkd.in/eJ5E24it

We can help you overcome the challenges of the competitive payer landscape. Let's connect to discuss your specific needs at:
https://lnkd.in/eadTaaSM

#PharmaceuticalMarketAccess #PayerRelations #DrugLaunchStrategies

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs